MCK - MCKESSON CORP


829.23
-13.020   -1.570%

Share volume: 1,106,282
Last Updated: 04-22-2026
Wholesale/Wholesale – Drugs & Drug Proprietaries: 0.06%

PREVIOUS CLOSE
CHG
CHG%

$842.25
-13.02
-0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
33%
Profitability 18%
Dept financing 47%
Liquidity 21%
Performance 48%
Company vs Stock growth
vs
Performance
5 Days
-3.47%
1 Month
-5.45%
3 Months
1.10%
6 Months
4.57%
1 Year
19.78%
2 Year
55.87%
Key data
Stock price
$829.23
P/E Ratio 
23.33
DAY RANGE
$821.99 - $847.05
EPS 
$34.82
52 WEEK RANGE
$637.00 - $999.00
52 WEEK CHANGE
$20.45
MARKET CAP 
101.246 B
YIELD 
0.37%
SHARES OUTSTANDING 
122.487 M
DIVIDEND
$0.82
EX-DIVIDEND DATE
03-02-2026
NEXT EARNINGS DATE
08-06-2025
BETA 
1.15
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$739,793
AVERAGE 30 VOLUME 
$744,278
Company detail
CEO: Brian S. Tyler
Region: US
Website: mckesson.com
Employees: 75,000
IPO year: 1994
Issue type: Common Stock
Market: NYSE
Industry: Wholesale/Wholesale – Drugs & Drug Proprietaries
Sector: Wholesale Trade

McKesson Corporation provides healthcare supply chain management, retail pharmacy, community oncology and specialty care, and healthcare information solutions. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions. The RxTS segment offers CoverMyMeds solution to help patients get the medications.

Recent news